Clinical Trials Browser

Unknown × OTHER × Carcinoma, Transitional Cell × Clear all

NCT03924466 2024-02-16

VUBAR

Phase 2 Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06120413 2023-11-07

18F-LN1 PET/CT in Urothelial Carcinomas

Carcinoma, Transitional Cell

NCT06113367 2023-11-02

VESUVIO

Carcinoma, Transitional Cell

NCT04543110 2023-03-23

RADIANT

Phase 2 Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05723991 2023-02-13

Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

Phase 4 Unknown

Carcinoma, Transitional Cell

NCT04730219 2022-11-30

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT05503563 2022-08-16

A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04718948 2022-05-09

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT04770974 2022-05-09

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02535650 2022-03-08

Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT04047693 2022-02-18

Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT03219775 2021-11-03

TITAN-TCC

Phase 2 Unknown

Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT04432909 2021-09-16

A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up

Carcinoma, Transitional Cell, Disease

NCT05043662 2021-09-14

UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.

Carcinoma, Transitional Cell, Ureteral Neoplasms

NCT05030077 2021-09-01

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT04773951 2021-08-24

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

Phase 1 Unknown

DermatologicGenitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma

NCT04211012 2020-11-13

A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT04568304 2020-09-29

A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Phase 3 Unknown

Carcinoma, Transitional Cell

NCT04295967 2020-03-05

Vasculogenic Mimicry in Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT04264936 2020-02-13

A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer

Phase 1/2 Unknown

Carcinoma, Transitional Cell

NCT04223063 2020-01-10

Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study

Phase NA Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03998371 2019-06-26

Application of UCAD for Diagnosing Urothelial Carcinoma.

Carcinoma, Transitional Cell, Chromosome Aberrations, Disease

NCT03745911 2018-11-19

Paclitaxel and TAK-228 in Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT03209206 2017-12-22

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT03296306 2017-09-28

FOCUS

Phase 3 Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT03280459 2017-09-12

iRARC-KSW

Carcinoma, Transitional Cell, Postoperative Complications

NCT03193788 2017-06-21

PREMIER

Phase 3 Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

NCT02278978 2015-05-12

BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT01993966 2013-11-25

EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells

Carcinoma, Transitional Cell

NCT00867633 2012-02-22

Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

Carcinoma, Transitional Cell

NCT01378052 2011-06-22

DNA Methylation and Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT01360723 2011-05-27

DNA Methylation and Arsenic-associated Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT01189838 2010-10-07

The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma

Carcinoma, Transitional Cell, Neoplasms

NCT00854464 2009-03-03

Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT00146276 2006-09-27

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell